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The Briard Problem
Abstract
The Briard breed has stimulated some ophthalmic interest in Canada, Europe, and the United States.
Ophthalmoscopic changes similar to central progressive retinal atrophy have been diagnosed. This report adds
further insight into the type of retinal degeneration and questions the associated physical findings as they may
relate to the retinal disease.
Disciplines
Eye Diseases | Medicine and Health Sciences | Ophthalmology | Veterinary Medicine
This conference paper is available at ScholarlyCommons: https://repository.upenn.edu/vet_papers/108
THE BRIARD PROBLEM 
Ronald C. Riis, DVM, MS, DACVO 
'Nw York State College of Veterinary Medicine 
Cornell University 
Ithaca, Nw York 14853 
Gustavo D. Aquirre, DVM, DACVO 
School of Veterinary 1\hi cine 
University of Pennsylvania 
Philadelphia, Pennsylvania 19104 
'I"re Briard breed has stimulated !Olle ophthalmic interest in Canada, 
Europe, and the United States. Ophthalmoscopic changes similar to central 
progressive retinal atrophy have been diagnosed. This report adds further 
insight into the type of retinal degeneration and questions the associated 
physical findings as they may relate to the retinal disease. 
CASE REPORT 
Eight puppies (born June 7, 1982) were produced from a'mating of a male 
with questionable visual ability at night to a nonnal female. Three (2 males 
and l female) of the pups were sold and no record of ocular examinations were 
available. Too ( 1 female and 1 male) were evaluated to be normal 
ophthalmoscopically and functionally. Three (2 female and l male) were noted 
to be functionally night-blind by 6 months of age or before. The owners 
requested ocular evaluations of Dr. David Covitz who also diagnosed nystagmus 
in 2 of the 3 night-blind puppies. Dr. Covitz requested an ERG evaluation at 
Cornell University on March 4, 1983. 
The ocular evaluations were essentially similar with the exception of 
nystagmus absent from 1 female. All displayed an absent menace reflex. All 
pupils were dilated but responsive to bright light stimulation. 1he fundus 
evaluations found good vasculature and tapetal nontapetal character. A 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
-
-2-
horizontal greenish sheen band approximately l disc diameter above the T-NT 
border gave the central retina a questionable hyperreflective zone. 
l\1a2e testing in a darkened room showed a functional night blindness m all 
dogs. 
The neurological examination by 0: deLahunta found only rapid vertical 
pendular nystagmus present most of'the time but occasionally stopping briefly 
with voluntary globe movement The nystagmus was not vestibular in origin, 
therefore, suspectedly associated with congeni ta 1 /hereditary retinal disease. 
An electroretinogram, under oxym01phone and acepromazine, was performed by 
Dr. l.oew. Flat recordings were found on a 11 dogs. 
The night-blind female with nystagmus was donated for further study. 
Sennn and plasma was taken from all dogs for vitamin A and E analysis. From 
the donated female, samples of blood were also taken for analysis of complete 
hemogram, enzymes, minerals including zinc, protein, and lipid profiles. A 
thyroid 14 base and post T 4 TSH was also submitted. Several fluorescein 
retinal angiogram were performed over the course of 6 months. 
RESULTS 
The in it i a I serum and plasma for vitamins A and E were very lipemic. An 
18-hour fasting sample was less lipemic. All samples were found to have nonnal 
A levels around 2,000 IU/1 00 ml • The E values were also normal ranging between 
317-326 ug%. The dialuric acid hemolysis test ranged from 3-4%. Thyroid 
function tests were within normal. A mild hypercholesterolemia and 
hypoproteinemia were found over repeated evaluations. 
During the 6 months of evaluation within the clinic, there has been 
constant problems with diarrhea and intermittent fever unassociated with 
infectious disease or parasites. Within the first wa:k of donation, one eye 
was removed for light and F.M histological evaluation. 1he nystagmus of the 
-,)-
remaining eye disappeared following the surgery. 1he light microscopic 
evaluation found only vacuolation of the RPE and a suggestion of photoreceptor 
thinning in the central retina. 1M evaluation showed the RPE filled with 
osmiophilic bodies in all areas of the retina. These cytoplasmic inclusion 
bodies were nonmembrane bound and with increasing magnification the morphology 
remained very homogeneous. 1he inclusions had a smooth outline and ranged in 
size similar from mitochondria to RPE nuclei. 1be mnnber of inclusion bodies 
within the RPE were more numerous in the central retina than the periphery. 
The RPE cytoplasm vvas abundantly active with smooth endoplasmic reticulum 
(Figure 1). Throughout the retina outer, segments were vesiculated, disrupted, 
or showing severe degeneration. Occasionally an intact photoreceptor remained, 
especially in the periphery of the retina. N> other abnormalities were noted 
in the remaining retinal layers. 
The visual ability of the donated Briard remained functionally stable over 
6 months. She managed or compensated visually in lighted situations only. 
Conversations with the breeder indicated a very similar course in the litter 
brother and sister. 
A repeat ERG a t 14 months of age gave a f1 at response. A small 
visual-evoked response (VER) was recorded (Figure 2). Several fluorescein 
angiogram wre performed over the 6-month period. The analysis of the 
injections did not display either a generalized hyperfluorescence or a blockage 
in fluorescence (Figure 3). 
~ 
In man, Refsum's disease (a recessive disorder characterized by an 
accumulation of pbytanic acid and peripheral neuropathy, ataxia, deafness, and 
retinal degeneration), the RPE as well as other ocular tissues are heavily 
laden with lipid. It is thought that the retinal degeneration may be the 
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result of RPE damage by accumulated lipids. These patients complain of a 
severe night blindness initially. 35 
Lipid droplets or inclusions in animal RPE are observed infrequently. 
65 
Experimentally lipid bodies in the RPE of rats were characteristic of dithizone 
or 1,10 phenanthroline treatment. 16 The lipid inclusion bodies were thought to 
be the result of a complex of dithizone or 1,10 phenanthroline-metal with lipid 
vitamin A metabolites. Identical results were obtained with these two zinc 
chelators and no effect~ observed with a chemical analogue (1 ,5 
phenanthroline) that does not have an affinity for zinc. The mechanism whereby 
administration of zinc chelators results in the appearance of irregular lipid 
inclusion bodies in rat RPE is obscure. 17 'Ih! reports of zinc chelator 
retinotoxicity in dogs do not include lipid inclusions within the RPE. 
A slightly different morphology of the lipid inclusion bodies was apparent 
m the Briard RPE. Rather than irregular scalloped edges, the Briard lipid 
inclusions are smooth and comparably larger in size. They are osmiophilic, 
nomnembrane found, and homogeneous throughout. They do not resemble lipofuscin 
or ceroid profiles in the RPE. 28 It is unlikely that these inclusions are 
derived from phagocytized photoreceptor outer segment discs or degenerate 
products. A worthy thought. might relate to the role smooth endoplasmic 
reticulum plays in the production and metabolism of fatty acids within the RPE. 
The role zinc, vitamin A, and lipoproteins play in night vision has been 
associated in human cases of chronic alcoholic cirrhotic, and chronic 
pancreatitis. Impairment of dark adaptation, ERG, and retinal structural 
. 23 34 defects have been reported m man. ' 
The assessment of zinc levels ~ be related to dermatological or growth 
manifestations. 1be Briards showed neither of these manifestations. The serum 
zinc values were found to be normal. 1he vitamin A and E levels were found to 
-!)-
be normal in the Briards upon initial evaluation. Pancreatic and liver 
function tests were also normal. 
bb 
In piperdylchlorophenothiazine (NP 207) retinotoxicity in cats, lipid 
deposition within the RPE was thought to be related to the degeneration. The 
lipid was believed to contain visual pigment shed from rod outer segments. 23 
~ ophthalmoscopic signs of a pigmented horizontal band near the optic disc is 
similar to the signs first noted in the Briard retinal degeneration. (NP 207 
does not produce retinotoxicity in dogs, rabbits, or rats). No phenothiazine 
type tranquilizers or antiemetic agents were given to the Briards. 
If the lipid inclusion bodies of the RPE contain derivatives which could 
cause lyposomal instability and the release of proteolytic enzymes into the 
cytoplasm of the RPE, degenerative effects upon the outer segments of the 
photoreceptors is predictable. The interference of the notmal biosynthesis of 
visual pigment and the metabolism of the RPE proceeds to a "futile cycle". 
An associated physical finding in the Briard was intermittent fever. 
Early AM rectal temperatures taken consistently showed several days of 
l03.0-104.0°F temperatures which would return to the notmal range and then 
repeatedly elevate again. This continued over many months. Plasma evaluations 
taken during febrile episodes were lipemic. A report of a child with 
idiopathic hyperlipemia also noted hyperthermia, headache, anxiousness, and 
intervals of delerium. 1 Ocular manifestations of primary or secondary 
hyperlipemia in dogs ranges from signs of corneal arcus, lipid aqueous, uveitis 
lipemia retinal is, and retinopathy.l2, 14,26,31 ,32,37 
Although lipemia retinalis has been seen in the dog and in all types of 
hyperlipoproteinemias in hwnans,7- 10 v.e were never convinced of this finding in 
the Briards. ~ young age lillY have been a factor or the relative amounts of 
circulating lipids. In respect to the hypercholesterolemia and an elevated 
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beta-lipoprotein (LDL} 1n the Briard with the lipid inclusions, a pursuit of 
nonnal dog 1 ipoprotein evaluation versus abnormal was taken. Nmnerous 
publications have establ'ished the nonnal dog values. 2·•6• 13 ,20,21 ,29,30 
In humans, familial hypercholesterolemia has been given rm:h attention as 
an inborn metabolic disorder. In Wdnm syndrome and cholesterol-ester-storage 
disease, the lysosomal acid lipase that hydrolyzes the cholesteryl esters of 
low-density lipoprotein is deficient. 4 ' 11 As a result, the esters accumulate 
in lysosomes in tissues throughout the body. 33 A lack of suppression of 
cholesterol synthesis and in stimulation of cholesterol esterification could 
also show accumulations in tissues. 
Cholesterol-synthesis inhibitors lower plasma levels of LDL cholesterol 1 n 
humans and animals. Compactin , discovered by Endo e t a 1 • , is a fungal 
metabolite isqlated :from Penicillium citrinum. 29 Mevinolin, is produced ~ 
Monascus species, and is a structural analogue of compactin but more potent. 
Both of these compounds are potent reversible inhibitors of 3-hydroxy-3 
methylylutaryl coenzyme A reductase. 19 •36 
According to studies of ( 1151) LDL turnover 1 n dogs, mevinolin lowers 
plasma LDL levels by a dual mechanism: suppression of LDL synthesis and 
stimulation of receptor-mediated catabolism of LDL in the 1 i ver. 15 In cultured 
porcine hepatocytes, an increase in receptor-mediated degradation of LDL was 
also demonstrated after 18 hours of incubation with compactin. 27 
Compactin used in dogs preferentially reduces beta-lipoprotein 
(corresponds to LDL) in contrast to alpha-lipoprotein, suggesting it as a 
useful drug for the prevention and treatment of atherosclerosis. 19,36 No 
adverse effects were found in dogs on a dosage of I 00-400 mg/k.g/day in 
1 . 15 ong-term expenments. 
_,_ 
A block in low-density lipoprotein metabolism at the receptor level would 
account for an inappropriate level of total cholesterol Production relative to 
elevated low-density lipoprotein and a reduction in the rate of fractional 
catabolism of LDl. 18 ,35 s30 
The overproduction of cholesterol may result from the inability of 
peripheral cells to use the cholesterol present in the lipoprotein for 
suppression of the rate controlling enzyme, 3-hydroxy-3 methylglutaryl coenzyme 
A reductase. This assumes that the RPE smooth endoplasmic reticulum i s 
1nvo1 ved in the production of the lipid inciting the retinal degenerative 
process. 
To test this thought in the Briard problem, it was necessary to find out 
if inhibitors could affect the lipid within the RPE and hence the retinal 
degenerative process. Compactin (200 mg/kg/day) was given for 1 month. Lipid 
levels as well as ERG functions were monitored during this time period. 1be 
results will be discussed. 
1m thought of lipid inclusions being a component of primary photoreceptor 
degeneration and-vitamin A lipid sequestration may relate to inherent metabolic 
and/or nutritional etiologies. Studies to challenge this will be discussed. 
The electrophysiologic findings are interesting in that the lack of ERG 
response is similar to retinitis punctata albescens in man. The Briard ERG 
will be discussed. 
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Figure 1 -Night blind Briard at 10 months of age. The lower left insert shows the RPE vacuolation indicative of the 
spaces where I i pi d was dissolved by the routine processing for I i g h t microscopic evaluation. The electron 
micrograph of the same retina but within the nontapetal area shows the content of these spaces. By preserving the 
1 i pi d within the RPE with osmium, these very symmetrical homogeneous inclusions can be observed. Photoreceptor 
degeneration is depicted in the a1 sections but it: is not obvious In the dorsal tapetal 1ig ht microscopic section. 
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ue 2 - The electrophyslologlc tracings of a Briard 14 months of age. The photopic visual-evoked response recordings 
shows a small response from each eye. Scotopic stimulus was negative as was the electroretinogram on the bottom I 
tracing. 
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=igure 3 ·Fluorescein angiogram showing (a) normal vascular filling in the nontepetal area just below the area 
centralis ... The area displayed In (b) was 10 seconds after (a). A fluorescein leak developed just below the 
tapetal-nontapetal junction. In a late veinous phase (c), a fluorescein haze indicates sare minor perivascular 
leakage. A focal blockage· of fluorescence can be noted from the choroidal background fluorescence along the tapeta 
nontapctal junction. 
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